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1. Introduction 
Black widow spider toxin (BWSTx), is a neuro- 
toxin purified from the venom of the spider Lafrodec- 
tus mactans tredecimguttatus [ 1] . BWSTx when 
tested on synaptosomes [ 1,2] , seems to reproduce 
the physiological events hown to occur at the neuro- 
muscular junction of the frog [3], lobster [4] and 
locust [S] after treatment with crude venom: namely 
a massive release of transmitters. A superfusion meth- 
od of synaptosomes, based on the detection in the 
perfusate of previously accumulated radioactive trans- 
mitter has proved to be a highly successful technique 
for the study of transmitter release mechanism [6,7]. 
The recent report [8] , that preincubation of 
cultured neuromuscular junctions with low concen- 
tration of Concanavalin A (Con A), inhibits the trans- 
mitter release caused by the spider venom, prompted 
us to study this effect on the efflux of previously 
accumulated y-amino [‘*Cl butyrate, from synapto- 
somes. 
We present here evidence that BWSTx stimulates 
the release of radioactive y-amino butyrate (GABA) 
from synaptosomes and that preincubation of 
synaptosomes with micromolar concentrations of
Con A abolishes the effect of the toxin. 
2. Experimental procedures 
BWSTx was purified from venom glands extract 
by gel permeation and ion exchange chromatography 
as reported [ 11. Toxicity data as well as comparison 
of the chemical and physical properties of the toxin 
ElsevierfNorth-Holland Biomedical &ess 
suggest considerable similarity with Bs fraction puri- 
fied [9]. 
Synaptosomes were prepared from male rat fore- 
brain, in a sucrose Ficoll system, according to [lo]. 
After washing the synaptosomes were resuspended 
in a buffered medium at a concentration of about 
2 mg total synaptosomal protein ml-‘, and incubated 
with a GABA mixture giving a final concentration of 
1 r.lCi y-amino [14C]butyrate and 1 PM GABA in 
presence of 10 I.~M aminooxy acetic acid (AOAA) 
for 10 min at 37’C. Synaptosomes were diluted to 
1 mg total proteins ml-‘, and 1.5 ml aliquots were 
transferred into 0.65 pm Millipore filters 
(DAWP02500) prepared on teflon superfusion units 
similar in design to those described [ 1 I] . Synapto- 
somes uperfusion was carried out essentially by the 
method described [6,1 I], except hat the temper- 
ature was kept at 25°C. After a double wash by 
vacuum suction the plated synaptosomes were per- 
fused by the constant suction of a peristaltic pump 
run at about 40 ml/h. About 0.7 ml effluent was 
collected, every minute, directly in the scintillation 
vials and the radioactivity counted in 8 vol. Aquasol. 
Since the presence of 10 E.~M AOAA was kept 
constant hroughout the experiment the radioactivity 
released represents more than 95% total y-amino 
[ 14C] butyrate as assayed by amino acid analysis [6] . 
For Con A experiments, the final synaptosomal 
suspension was incubated in the presence of Con A 
(A grade Calbiochem), for 30 min, at 25’C in a water 
bath under mild agitation (100 rev/min, New Brunswick 
Scientific Co.). The final Con A concentration was 
0.1 PM. The Con A treated synaptosomes were washed 
twice with incubation medium by successive centrifu- 
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gation at 40 000 X g for 15 min and the final pellet 
resuspended in incubation medium. The uptake and 
superfusion of radioactivity GABA was performed as 
mentioned above. 
As a control synaptosomes were treated exactly 
the same way except that 0.2 M cw-methyl-D-manno- 
side, a competitive inhibitor of Con A binding to 
sugars, was included in the Con A pretreatment step. 
Preliminary experiments indicated that Con A-treated 
synaptosomes take up GABA as efficiently as untreat- 
ed ones. With the exception of the experiments in 
presence of Con A for which an incubation medium 
free of glucose was used, the composition of incuba- 
tions and perfusion media was : 128 mM NaCl, 
4.7 mM KCl, 1.8 mM CaCl? , 1.4 mM MgCl, , 10 mM 
glucose and 20 mM N-2-hydroxyethylpiperazine- 
N-2 ethanesulfonic acid (Hepes) buffered at pH 7.4. 
All solutions were prepared in deionized, glass-distilled 
water from analytical grade reagents. 
Protein was estimated by the method [ 121 after 
precipitation with 100% trichloroacetic acid to 
eliminate sucrose and Hepes. Each experimental result 
presented in this paper was obtained at least three 
times on duplicate samples: representative xperi- 
ments are illustrated. 
3. Results 
As shown in fig.1, BWSTx markedly stimulated 
the release of y-amino [‘4C]butyrate. In the 3-5 min 
perfusion during which BWSTx was present at con- 
centration varying from 0.05,0.5 and 3 pg/ml, an 
increase in transmitter release from 1 S- to almost 
5-fold that of controls was demonstrable. The effect 
of the toxin was rapid and the increase in transmitter 
release noticeable in the perfusate within l-2 min 
after toxin addition and lasted for 5-6 min. In the 
same experimental conditions, a perfusing medium 
having 56 mM KC1 replacing an equimolecular con- 
centration of NaCl exerted a stimulatory effect on 
GABA similar in time response to that obtained with 
BWSTx. 
In order to exclude that BWSTx action could be 
simply explained by synaptosomes disruption, lactate 
dehydrogenase activity was measured in the super- 
natant after treatment of synaptosomes with the toxin 
and compared with the activity released after treat- 
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F&l. Effect of BWSTx on the release of r-amino [“Cjbuty- 
rate from rat brain synaptosomes. After plating on Millipore 
filters, synaptosomes aliquots were filtered washed and super- 
fused with incubation medium, as described in the text. At 
7 min various concentrations of toxin were simultaneously 
introduced by a complete change of perfusing medium in 
parallel chambers. A medium containing 56 mM K+ was used 
as an indicator that synaptosomes were viable and responded 
to depolarization. The double arrow indicates the period 
during which the toxin and high K+ were present in the media 
perfusing synaptosomes. The superfusion rate was about 
0.7 ml/min, and the radioactivity released is expressed as 
percentage of total radioactivity (fractions plus filter at the 
end of superfusion). (o---o) Control; (*---a) 0.05 pg 
BWSTx/ml; (a ----A) 0.5 pg BWSTx/ml; (o- 0) 3 Ecg 
BWSTx/ml; (X - -X), 56 mM KCl. Cumulative curves are 
given. 
ment with 0.1% Triton X-100. After 20 min incuba- 
tion lactate dehydrogenase activity was 3% that of 
Triton X-100 treated samples and 1.5 times that of 
untreated controls. 
Figure 2 shows the effect of pre-treating the 
synaptosomes with Con A on the toxin-dependent 
release of y-amino [14C]butyrate. In one set of expe- 
riments synaptosomes treated with Con A and loaded 
with radioactive GABA were perfused and the effect 
of 1 I.cg/ml BWSTx and depolarizing concentrations 
of K’ tested. Synaptosomes treated with the same 
amount of Con A but in presence of 0.2 M ar-methyl- 
Volume 85, number 2 FEBS LETTERS January 1978 
5 10 
Perfusion Time 
Fig.2. Effect of Con A pretreatment on the release of r-amino 
[‘4C]butyrate stimulated by BWSTx, in rat brain synapto- 
somes. The synaptosomal fraction was incubated with 
0.1 NM Con A or 0.1 PM Con A in presence of 0.2 M 
ar-methyl-D-mannoside. The synaptosomes were then centri- 
fuged washed and incubated for r-amino [ 14C] butyrate 
uptake. Aliquots of the suspension were plated on Millipore 
filters, filtered washed and superfused with perfusion medium 
as described in fgl. (X-X) Control synaptosomes pre- 
treated with Con A; (o- -0) 1 c(g BWSTx/ml on synapto- 
somespretreated with Con A; (o- -0) 56 mM KC1 on synap- 
tosomes pretreated with Con A; (o- -0) 1 c(g BWSTx/ml on 
synaptosomes pretreated with Con A but in presence of 
0.2 M cu-methyl-D-mannoside. The molecular weight of 
Con A was assumed to be that of the tetramer (110 000). 
D-mannoside were used as controls. While Con A 
treated synaptosomes were susceptible to the depola- 
rizing action of 56 mM KC1 they were not susceptible 
to the toxin action and the consequent stimulation of 
GABA release was abolished. Control synaptosomes 
on the contrary were responsive to the toxin. Neither 
Con A nor a-methyl-D-mannoside added to the perfu- 
sion fluid had a striking effect on the release of GABA 
from perfused synaptosomes. Affinity chromatog- 
raphy experiments of the purified toxin run at 4”C, 
indicated that it has no specific affinity for Con A 
covalently bound to Sepharose 4B. 
4. Discussion 
Two main findings are reported here: one is that a 
toxin purified from black widow spider venom mar- 
kedly increases the release from synaptosomes prepa- 
rations of previously accumulated radioactive GABA, 
the second is that this effect is blocked by pretreat- 
ment of the synaptosomes with Con A. The effect on 
GABA release was obtained with ldw concentrations 
of toxin; a 0.38 nM solution of toxin, based on the 
est. mol. wt 130 000 [ 1,9] was still effective. The 
action of the toxin is also remarkably rapid since 
immediately after its addition to the perfusing medium 
an increased amount of transmitter was noticeable in 
the perfusate. It is also clear that in the experimental 
system used, depolarization achieved by superfusing 
synaptosomes with high K+ medium, caused release of 
GABA with a pattern having a similar time-lag. The 
toxin does not appear to cause a non-specific mem- 
brane damage as judged by comparing the amount of 
lactate dehydrogenase released from synaptosomes 
after toxin with that induced by treatment with the 
detergent Triton X-100. 
There is evidence that a given lectin reacts with a 
unique population of oligosaccharides and does not 
show common receptors with other lectins [ 131. 
Con A binds to mannopyranosyl and glycopyranosyl 
residues, therefore treatment of synaptosomes with 
Con A probably brings to the formation of glyco- 
conjugates with membrane proteins containing these 
sugars. The formation of these complexes prevents 
the releasing action of the toxin, but does not affect 
the release induced by depolarization. It is tempting 
to speculate the existence in the synaptic plasma 
membrane of a glycoprotein actin as a receptor for 
the toxin. The possibility that BWSTx has affinity for 
mannopyranosyl groups can however be ruled out 
since incubation of the toxin with exceeding concen- 
trations of methyl-D-mannoside id not affect the 
venom action. It is more probable that as a result of 
the lectin-membrane interaction, changes in the 
arrangement of surface and glycoproteins occur [ 141. 
This could prevent he interaction of the toxin with 
some membrane component; alternatively it could 
prevent either the modification or the redistribution 
of the same component, astep probably necessary for 
toxin stimulated release. BWSTx may provide a means 
of characterising a structure of the presynaptic mem- 
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brane which appears to be involved in transmitter 
release functions. 
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